To investigate the relationship between PFDN3 expression and disease progression, the Kaplan-Meier method was used to evaluate the patients’ overall survival relative to PFDN3 expression in ccRCC tumors. The gene discussed is VBP1; the disease is nonpapillary renal cell carcinoma.